Development and validation of a nomogram for predicting osteoporosis in prostate cancer patients: A cross‐sectional study from China

This study constructed two reliable nomograms to predict osteoporosis and bone loss, integrating personal health information and PCa-specific treatment data. These nomograms offer an easy and individualized approach to predict the occurrence of osteoporosis and bone loss in PCa patients.